Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer

Gastric cancer has one of the highest mortality rate in the world, but the treatment is still limited. Building on previous studies, mechanistic studies on propranolol in gastric cancer mice models and gastric cancer patients were performed. Propranolol inhibited the in vitro proliferation of gastri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qian, Liao, Ping, Li, Wei, Hu, Jiali, Chen, Cuiyu, Zhang, Yu, Wang, Yang, Chen, Ling, Song, Kun, Liu, Jie, Zhang, Wei, Li, Qing, McLeod, Howard L., He, Yijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108985/
https://www.ncbi.nlm.nih.gov/pubmed/33981600
http://dx.doi.org/10.3389/fonc.2021.628613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108985/
https://www.ncbi.nlm.nih.gov/pubmed/33981600
http://dx.doi.org/10.3389/fonc.2021.628613

Ejemplares similares